共 50 条
- [3] Sclerostin as a biomarker of cardiovascular risk in women with systemic lupus erythematosus [J]. SCIENTIFIC REPORTS, 2022, 12 (01):
- [6] Systemic lupus erythematosus and the risk of perioperative major adverse cardiovascular events [J]. Journal of Thrombosis and Thrombolysis, 2018, 45 : 13 - 17
- [7] Cardiovascular events in patients with systemic lupus erythematosus [J]. COR ET VASA, 2014, 56 (02) : E145 - E152
- [8] CARDIOVASCULAR RISK IN SYSTEMIC LUPUS ERYTHEMATOSUS [J]. ATHEROSCLEROSIS, 2019, 287 : E190 - E190
- [9] Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus [J]. LUPUS SCIENCE & MEDICINE, 2021, 8 (01):